Provided by Tiger Trade Technology Pte. Ltd.

TriSalus Life Sciences Inc.

4.15
-0.1600-3.71%
Post-market: 4.150.00000.00%19:30 EDT
Volume:273.18K
Turnover:1.13M
Market Cap:254.42M
PE:-3.12
High:4.27
Open:4.27
Low:4.02
Close:4.31
52wk High:7.95
52wk Low:2.20
Shares:61.31M
Float Shares:43.63M
Volume Ratio:0.61
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3300
EPS(LYR):-1.8389
ROE:-496.21%
ROA:-36.75%
PB:38.84
PE(LYR):-2.26

Loading ...

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM

Reuters
·
May 13

TriSalus Life Sciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

TriSalus Life Sciences Q1 EPS $0.03 Beats $(0.16) Estimate, Sales $8.899M Miss $10.440M Estimate

Benzinga Earnings
·
May 13

TriSalus swings to Q1 FY26 profit of $1.5 million; revenue falls 2.9% to $8.9 million

Reuters
·
May 13

TriSalus Life Sciences Inc - Revises 2026 Revenue Guidance to $54 Mln-$57 Mln

THOMSON REUTERS
·
May 13

TriSalus Life Sciences Reports First Quarter 2026 Results Demonstrating Commercial and Clinical Progress for Facilitating Long-Term Growth

THOMSON REUTERS
·
May 13

TriSalus Life Sciences Q1 Pretax Profit USD 1.543 Million

THOMSON REUTERS
·
May 13

TriSalus announces journal publication of PEDD study

TIPRANKS
·
May 13

TriSalus PEDD real-world study shows $7,734 charge avoidance, improved outcomes in liver cancers

Reuters
·
May 12

TriSalus Life Sciences Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
May 09

Lake Street Remains a Buy on TriSalus Life Sciences (TLSI)

TIPRANKS
·
May 05

TriSalus launches PREDICTT trial testing pressure-enabled delivery in Y90 liver tumor therapy

Reuters
·
May 05

TriSalus Life Sciences Announces Launch of Predictt Clinical Trial Evaluating Pressure-Enabled Drug Delivery in Liver Tumors

THOMSON REUTERS
·
May 05

TriSalus Chief of Clinical Operations Devlin to retire Oct. 1

Reuters
·
Apr 30

Press Release: TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference Call

Dow Jones
·
Apr 29

TriSalus Life Sciences to host first-quarter financial results conference call

Reuters
·
Apr 29

Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and TriSalus Life Sciences (TLSI)

TIPRANKS
·
Apr 29

TriSalus publishes investor presentation on pressure-enabled drug delivery for solid tumors

Reuters
·
Apr 15

TriSalus to present new PEDD clinical, preclinical data at SIR 2026 meeting

Reuters
·
Apr 10

TriSalus Life Sciences Appoints Richard Marshall, M.d., as Chief Medical Officer

THOMSON REUTERS
·
Apr 07